BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12022252)

  • 1. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
    Psaty BM; Weiss NS; Furberg CD
    Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conflicting evaluations of the PROGRESS Study].
    Hausberg M; Kosch M; Rahn KH
    Internist (Berl); 2003 May; 44(5):631-2. PubMed ID: 12966791
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
    Schiffrin EL
    Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
    [No Abstract]   [Full Text] [Related]  

  • 4. The PROGRESS trial three years later: time for a balanced report of effectiveness.
    Wennberg R; Zimmermann C
    BMJ; 2004 Oct; 329(7472):968-70. PubMed ID: 15499116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of PROGRESS: questions and answers.
    Chalmers J; Adams HP; Donnan GA; Fox K; MacMahon S; Mancia G; Tzourio C
    J Hypertens Suppl; 2003 Jun; 21(5):S21-4. PubMed ID: 12953852
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
    Matsumoto M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938
    [No Abstract]   [Full Text] [Related]  

  • 7. The PROGRESS trial three years later: time for more action, less distraction.
    Macmahon S; Neal B; Rodgers A; Chalmers J
    BMJ; 2004 Oct; 329(7472):970-1. PubMed ID: 15499117
    [No Abstract]   [Full Text] [Related]  

  • 8. [PROGRESS].
    Hasegawa Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
    Schiffrin EL
    Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
    [No Abstract]   [Full Text] [Related]  

  • 10. Invited commentary. Stroke preventive treatment using perindopril and indapamide in the context of Indian primary care.
    Wennberg RA; Zimmermann C
    Neurol India; 2007; 55(2):101-2. PubMed ID: 17558107
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of recurrent stroke in primary care during preventive treatment based on perindopril with or without indapamide.
    Padma MV; Kaul S
    Neurol India; 2007; 55(2):141-4. PubMed ID: 17558118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROGRESS results: implementation in stroke guidelines.
    Donnan GA
    J Hypertens Suppl; 2003 Jun; 21(5):S25-8. PubMed ID: 12953853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
    Masson C
    Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary prevention for stroke and transient ischaemic attacks.
    Muir KW
    BMJ; 2004 Feb; 328(7435):297-8. PubMed ID: 14764462
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of arterial hypertension in stroke prevention].
    Britov AN; Bystrova MM; Orlov AA
    Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
    Ratnasabapathy Y; Lawes CM; Anderson CS
    Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of perindopril in the prevention of stroke.
    Papadopoulos DP; Votteas V
    Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):283-9. PubMed ID: 18221093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.